National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Supportive care


Active


18 and over


Pharmaceutical / Industry


A0081128
NCT00381095

Last Modified: 5/21/2008     First Published: 1/5/2007  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Supportive care


Active


18 to 80


Pharmaceutical / Industry


PFIZER-A0081124
RAH-060919, NCT00380874

Last Modified: 5/20/2008     First Published: 3/6/2008  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 to 70


Other, Pharmaceutical / Industry


SCCC-022006-010
022006-010, PFIZER-SCCC-022006-010, NCT00631891


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Approved-not yet active


18 and over


Other


80-82310-98-8612
NCT00740571

First Published: 3/4/2008  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Supportive care


Active


Over 18


Other


CHUV-Neurology-CePO–LEV/PGB
CHUV-Neurology-CePO–LEV/PGB, EU-20807, NCT00629889


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Supportive care


Active


18 and over


Other


NEUROPAIN01
EudraCT Number 2007-005222-69, NCT00637975

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov